Session Details
[3MS-01]【J】A new horizon of cancer 3D research
Fri. Dec 5, 2025 11:15 AM - 12:35 PM JST
Fri. Dec 5, 2025 2:15 AM - 3:35 AM UTC
Fri. Dec 5, 2025 2:15 AM - 3:35 AM UTC
Room 1(Pacifico Yokohama Conference Center 1F, Main Hall)
Organizer: Koji Okamoto (Teikyo University), Noriko Gotoh (Kanazawa Univeristy)
Heterogeneity and plasticity of cancer are closely associated with refractory nature of cancer such as drug resistance and metastatic potential and understanding these properties is essential for advancing cancer therapy. 3D culture systems, such as organoids and spheroids, have proven to be valuable tools for cancer research, as they can replicate these features of cancer in vitro. This symposium will highlight research utilizing 3D cultures to explore the fundamental nature of clinical cancers.
[3MS-01-01]Understanding of refractory cancer through integration of spatial omics and 3D culture
○Koji Okamoto1 (1. Teikyo Univ. ACRO)
[3MS-01-02]The role of fibrotic microenvironment in cholangiocarcinoma development
○Hiroko Oshima1, Satoshi Takada3, Shintaro Yagi3, Masanobu Oshima1,2 (1. Div.Genetics, Cancer Res. Inst., Kanazawa Univ. , 2. WPI-Nano LSI, Kanazawa Univ. , 3. Dept. Hepato -Biliary-Pancreatic Surg and Transplantation, Kanazawa Univ.)
[3MS-01-03]Establishment of 3D culture systems derived from female cancer patients and their application to therapeutic target identification and treatment models
○Kazuhiro Ikeda1, Kuniko Horie1, Satoshi Inoue1,2 (1. Saitama Medical University, 2. Tokyo Metropolitan Institute for Geriatrics and Gerontology)
[3MS-01-04]Heterogeneous breast cancer cells leverage bone marrow cell plasticity at the single-cell level to drive metastasis initiation
○Noriko Gotoh1 (1. Cancer Research Institute, Kanazawa University)